Weikang Xu

Guangzhou, 510260, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Corrigendum to "Machine learning algorithms develop a tumor-educated platelets-related gene signature to predict colorectal cancer prognosis and therapy response" [iScience 29 (2026) 116229].

Corrigendum to "Machine learning algorithms develop a tumor-educated platelets-related gene signature to predict colorectal cancer prognosis and therapy response" [iScience 29 (2026) 116229].

Journal: iScience
Published: August 28, 2026

Correction: Targeting fibroblast activation protein-α to treat renal fibrosis.

Correction: Targeting fibroblast activation protein-α to treat renal fibrosis.

Journal: Cellular & molecular biology letters
Published: July 01, 2026

Machine learning algorithms develop a tumor-educated platelets-related gene signature to predict colorectal cancer prognosis and therapy response.

Machine learning algorithms develop a tumor-educated platelets-related gene signature to predict colorectal cancer prognosis and therapy response.

Journal: iScience
Published: July 24, 2025

Targeting fibroblast activation protein-α to treat renal fibrosis.

Targeting fibroblast activation protein-α to treat renal fibrosis.

Journal: Cellular & molecular biology letters
Published: March 16, 2025

Quinacrine Inhibits Hepatocellular Carcinoma Growth and Enhances the Anti-HCC Effects of Lenvatinib.

Quinacrine Inhibits Hepatocellular Carcinoma Growth and Enhances the Anti-HCC Effects of Lenvatinib.

Journal: Anti-cancer agents in medicinal chemistry
Published: May 20, 2024

Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy.

Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy.

Journal: International journal of biological sciences
Published: December 27, 2023

Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma.

Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma.

Journal: Cancer immunology, immunotherapy : CII
Published: November 15, 2023

A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.

A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.

Journal: Signal transduction and targeted therapy
Published: July 04, 2023

Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma.

Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma.

Journal: Frontiers in oncology
Published: November 11, 2021

Targeting cIAPs attenuates CCl4-induced liver fibrosis by increasing MMP9 expression derived from neutrophils.

Targeting cIAPs attenuates CCl4-induced liver fibrosis by increasing MMP9 expression derived from neutrophils.

Journal: Life sciences
Published: October 08, 2021

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma.

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma.

Journal: Frontiers in oncology
Published: April 26, 2021

Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.

Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.

Journal: Journal of computational biology : a journal of computational molecular cell biology
Published: March 14, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026